Anja Osterloh

Anja Osterloh

Auto-generated profile, based on publicly available information

Anja Osterloh

Department of Neuropathology, University of Ulm, Lindenallee 2, 89312 Günzburg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
APAndrej Pala
Andrej Pala
NGNadja Grübel
Nadja Grübel
AKAndreas Knoll
Andreas Knoll
GDGregor Durner
Gregor Durner
GEGwendolin Etzrodt-Walter
Gwendolin Etzrodt-Walter
Hlaváč MichalHlaváč Michal
Hlaváč Michal
Background/Objectives: Pituitary tumors account for over 90% of all sellar region masses. However, a spectrum of rare neoplastic, inflammatory, infectious, and vascular lesions—benign and malignant—can arise in the intra- and parasellar compartments and clinically and radiologically mimic PitNETs. We report a cohort of 47 such rare and cystic midline intracranial lesions, emphasizing their distinctive morphological, clinical, and imaging features and the personalized treatment strategies applied. Methods: In this retrospective single-center study, we reviewed all patients treated for suspected PitNETs via transsphenoidal approach between 2015 and 2024. Of 529 surgical cases, we excluded confirmed PitNETs, meningiomas, and classical intradural craniopharyngiomas. Collected data encompassed patient demographics, tumor characteristics, presenting symptoms, extent of resection or medical therapy, endocrine outcomes, and follow-up information. Results: Among all 529 patients who underwent surgical treatment for sellar lesions from 2015 to 2024, 47 cases (8.9%) were identified as rare or cystic masses. Forty-six underwent transsphenoidal resection; one patient with hypophysitis received corticosteroid therapy alone. Presenting symptoms included headache (n = 16), dizziness (n = 5), oculomotor disturbances (n = 2), and visual impairment (n = 17). Endocrine dysfunction was found in 30 patients, 27 of whom required hydrocortisone replacement. Histopathological diagnoses were led by colloid cysts (n = 14) and Rathke’s cleft cysts (n = 11). The remaining 22 cases comprised plasmacytoma, germinoma, lymphoma, pituicytoma, inverted papilloma, metastatic carcinoma, chordoma, nasopharyngeal carcinoma, chloroma, and other rare entities. Preoperative imaging diagnosis proved incorrect in 38% (18/47) of cases, with several lesions initially misidentified as PitNETs. Conclusions: Nearly 9% of presumed PitNETs were rare, often benign or inflammatory lesions requiring distinct management. Most could be safely resected and demonstrated excellent long-term outcomes. Yet, despite advanced imaging techniques, accurate preoperative differentiation remains challenging, with over one-third misdiagnosed. Clinical red flags—such as early hormone deficits, rapid progression or atypical imaging findings—should prompt early interdisciplinary evaluation and, when indicated, image-guided biopsy to avoid unnecessary surgery and ensure tailored therapy.

20 March 2025 in International Journal of Laboratory Hematology
Verified
Journal Article
Open access
BSBenedict Schwarz
Benedict Schwarz
CHChristopher Hardt
Christopher Hardt
KFKatharina Friedrich
Katharina Friedrich
MPMonika Prpić
Monika Prpić
AOAnja Osterloh
Anja Osterloh
AJAmir Jahic
Amir Jahic
Introduction: Automatic cytological analysis of cerebrospinal fluid (CSF) by Sysmex XN‐Series represents a convenient laboratory platform for quantitative examination of nucleated CSF cells (monomorphonuclear (MN), polymorphonuclear (PMN), high‐fluorescent (HF)). HF cells (HFC), a research laboratory parameter so far, seem to be associated with certain clinical patterns. Hence, we aimed to determine the diagnostic HFC value for different clinical categories in neurological settings.Methods: Morphological classification of automatically detected HFC was carried out using manual light microscopy. Automatic method precision for cell differentiation was evaluated in comparison. In 284 cases, multiple correlation strategies and mathematical disease modellings enabled an explorative analysis of HFC suitability for case stratification into the categories Hemorrhage, Inflammation, Neoplasia, other, and unknown.Results: Manual microscopic reevaluation revealed plasma cells, macrophages, and malignant cells being HFC correlates in 80% of automatically detected HFC. Method correlation for automatic and manual CSF cell differentiation approaches was 95%, yielding a negative bias of 4.3% for MN and positive bias of 0.4% and 3.9% for PMN and HF, respectively. When HFC were used as a “stand‐alone” predicting tool, diagnostic accuracy, specificity, and sensitivity depended on the clinical condition, ranging from > 0.5 up to > 0.7 for Hemorrhage, Inflammation, and Neoplasia. However, multiparametric correlation analyses combining laboratory CSF diagnostics and mathematical methods defined HFC as a relevant laboratory parameter for adequate clinical case stratification. With an expected random distribution of 25% for four clinical categories, almost 70% of cases were correctly classified when the HFC‐based mathematical algorithm was applied.Conclusion: HFC has significant diagnostic and/or predictive value for neurological diseases.

10 June 2025 in Onco
Verified
Journal Article
Open access
PDF file
NGNadja Grübel
Nadja Grübel
AWAnika Wickert
Anika Wickert
FSFelix Sahm
Felix Sahm
BSBernd Schmitz
Bernd Schmitz
AOAnja Osterloh
Anja Osterloh
MLMona Laible
Mona Laible
Gliomas are incurable, heterogeneous brain tumors, with rare forms often constituting diagnostic and treatment challenges. Molecular diagnostics, mainly implemented through the World Health Organization (WHO) 2021 guidelines, have refined the classification, but highlight difficulties in diagnosing rare gliomas remain. This case series analyzes four patients with rare gliomas treated at the University Hospital, Ulm, between 2002 and 2024. Patients were selected based on unique histopathological features and long-term clinical follow-up. Clinical records, imaging, and histological data were reviewed. Molecular diagnostics followed WHO 2021 guidelines. Quality of life was assessed using standardized tools including the EQ-5D-5L, EQ VAS, the Distress Thermometer, and the Montreal Cognitive Assessment (MoCA). In the first case, a 51-year-old male’s diagnosis evolved from pleomorphic xanthoastrocytoma to a high-grade glioma with pleomorphic and pseudopapillary features, later identified as a neuroepithelial tumor with a PATZ1 fusion over 12 years. Despite multiple recurrences, extensive surgical interventions led to excellent outcomes. The second case involved a young female with long-term survival of astroblastoma, demonstrating significant improvements in both longevity and quality of life through personalized care. The third case involved a patient with oligodendroglioma, later transforming into glioblastoma, emphasizing the importance of continuous diagnostic reevaluation and adaptive treatment strategies, contributing to prolonged survival and quality of life improvements. Remarkably, the patient has achieved over 20 years of survival, including 10 years of being both therapy- and progression-free. The fourth case presents a young woman with neurofibromatosis type 1, initially misdiagnosed with glioblastoma based on histopathological findings. Subsequent molecular diagnostics revealed a subependymal giant cell astrocytoma-like astrocytoma, highlighting the critical role of early advanced diagnostic techniques. These cases underscore the importance of precise molecular diagnostics, individualized treatments, and ongoing diagnostic reevaluation to optimize outcomes. They also address the psychological impact of evolving diagnoses, stressing the need for comprehensive patient support. Even in complex cases, extensive surgical interventions can yield favorable results, reinforcing the value of adaptive, multidisciplinary strategies based on evolving tumor characteristics.

17 November 2026 in Brain Pathology
Verified
Journal Article
Open access
DYDeniz Yilmazer-Hanke
Deniz Yilmazer-Hanke
PAPanagiotis Alexiou
Panagiotis Alexiou
ETElisa Tuzzi
Elisa Tuzzi
DWDiana Wiesner
Diana Wiesner
MLMona Laible
Mona Laible
JHJoachim Hanke
Joachim Hanke
In cerebral amyloid angiopathy (CAA), the relationship of perivascular β‐amyloid (Aβ) deposits to Aβ in vessel walls and AD‐related pathology is not fully understood. Here, we performed 3D analyses of vascular and perivascular circumferential/dyshoric Aβ deposits with Aβ17‐24‐ and Aβ1‐40‐labeling antibodies using single‐/double‐/multi‐label immunostaining in thick brain sections, and in tissue sequentially cleared with DEEP‐Clear and CUBIC‐L in human CAA. Arterial and capillary walls showed both Aβ1‐40 and Aβ17‐24 labeling, extending over several branching points, with vessel segments containing Aβ1‐40 considerably dilated. Ten distinct 3D arterial/arteriolar and capillary CAA categories were identified and quantified with Aβ17‐24 in the leptomeninges, and vascular layers (superficial, middle, deep, and juxtacortical) of nine cerebral cortical areas. While four categories reflected Aβ in arterial walls (tunica media and adventitia) and the perivascular brain parenchyma (fleecy or fibrillary), in six capillary CAA categories three showed gaps between dyshoric Aβ deposits and Aβ in capillary walls, and three were gapless (dyshoric Aβ deposits attached to capillary walls). Factor analysis extracted the factors “arterial CAA,” “Aβ load‐related capillary CAA” with gaps, and gapless “age‐related capillary CAA,” with factor 1 associated with the APOE ε4 genotype, factor 2 with cortical Aβ burden, and factor 3 with age. Leptomeningeal/superficial cortical vascular layers were more severely affected in “arterial CAA,” while the two capillary CAA types were prominent in middle/deep cortical layers. Layer and age distribution of Aβ1‐40 was similar to Aβ17‐24 in all three CAA types. Thus, our 3D CAA analyses using thick brain sections and light sheet microscopy distinguished arterial CAA from two different capillary CAA types. Opposite layer patterns of arterial and capillary CAA and the distinction of two capillary CAA forms based on their relationship either to Aβ load/APOE ε4 genotype or age suggests differences in CAA pathogenesis and mechanisms in pericapillary Aβ drainage.